Notice of Effectiveness (effect)
03 October 2022 - 09:58PM
Edgar (US Regulatory)
UNITED STATES |
SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549 |
NOTICE OF EFFECTIVENESS
|
|
Effective Date: |
September 30, 2022 4:5 P.M. |
Form: |
F-3 |
CIK: |
0001601936 |
Company Name: |
Altamira Therapeutics Ltd. |
File Number: |
333-267584 |
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Mar 2023 to Apr 2023
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Apr 2022 to Apr 2023